An evaluation of Mp1p antigen screening for talaromycosis in HIV-infected antiretroviral therapy-naïve population in Guangdong, China.
Dandan GongWeiyin LinHuihua ZhangXu OuLiya LiPengle GuoYaozu HeCong LiuWeiping CaiXiaoping TangLinghua LiPublished in: PLoS neglected tropical diseases (2023)
Mp1p antigen screening can be an effective tool for more efficient diagnosis of Talaromycosis, especially in HIV/AIDS patients with low CD4+ counts. Future validation studies are needed.